AMPTEC
LIVE

Serial Number

97712953

Owner

MERCK KGAA

Attorney

William C. Wright

Filing Date

Dec 12, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AMPTEC Trademark

Serial Number: 97712953 • Registration: 7395725

AMPTEC is a trademark filed by MERCK KGAA on December 12, 2022. The trademark is classified under Class 1 (Chemicals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MERCK KGAA (1,594 trademarks)

DARMSTADT 64293 , DE

Entity Type: 31

Trademark Details

Filing Date

December 12, 2022

Registration Date

May 28, 2024

Published for Opposition

March 12, 2024

Goods & Services

Custom manufacture of biopharmaceuticals; Custom manufacture of pharmaceuticals

Chemical and biochemical products for industrial, scientific or therapeutic purposes in the fields of pharmacy, biology, molecular biology, biochemistry, biotechnology and chemistry, including food chemistry, namely, chemicals for use in biotechnological product development; Chemical preparations and reagents, other than for medical or veterinary purposes, in particular, nucleic acid modifying enzymes and nucleic acid reagents; Diagnostic preparations other than for medical or veterinary purposes for molecular biology research and diagnostics, including research and diagnostic preparations containing the aforementioned reagents alone or in combination with other reagents as assemblies in the nature of consisting primarily of buffers, reagent components as part of kits or assemblies containing nucleic acids, for the processing or therapeutic application of pathogenic and non-pathogenic microorganisms and of nucleic acid molecules

Quality control for others, namely, conducting of quality control tests for manufacture of nucleic acids for research and therapeutic use; Consumer product safety testing for manufacture of nucleic acids for research and therapeutic use; Process monitoring for quality assurance for manufacture of nucleic acids for research and therapeutic use; Product quality testing services for manufacture of nucleic acids for research and therapeutic use; Product safety testing services for manufacture of nucleic acids for research and therapeutic use; Quality control for others, namely, providing quality assurance services for manufacture of nucleic acids for research and therapeutic use; Quality control of goods and services for manufacture of nucleic acids for research and therapeutic use; Scientific and technological services, namely, testing in the field of manufacture of nucleic acids for research and therapeutic use; Testing of pharmaceuticals; Testing of biologics in the nature of pharmaceuticals; Testing of biopharmaceuticals; Testing of raw materials; Development of pharmaceuticals preparations and medicines, namely, manufacture of nucleic acids for therapeutic use; Pharmaceutical drug development services for manufacture of nucleic acids for therapeutic use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 28, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 28, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2024 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 21, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2024 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 5, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 5, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 5, 2024 CNEA
ASSIGNED TO EXAMINER
Jan 11, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2024 CRFA
ASSIGNED TO LIE
Jan 10, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 15, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 7, 2023 CNRT
ASSIGNED TO EXAMINER
May 18, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2023 NWOS
NEW APPLICATION ENTERED
Dec 15, 2022 NWAP